Curcumin/Liposome Nanotechnology as Delivery Platform for Anti-inflammatory Activities via NFkB/ERK/pERK Pathway in Human Dental Pulp Treated With 2-HydroxyEthyl MethAcrylate (HEMA)
Nandi A, Yan LJ, Jana CK, Das N
In a statement, Novo Nordisk says extensive data from randomized trials, long-term studies, and real-world evidence "have not shown a causal relationship between use of GLP-1 receptor agonists and risk of thyroid tumors." The company "remains confident in the benefit risk profile of its products and remains committed to ensuring patient safety," the statement said
Although these receptor systems are distinct, both participate in metabolic and endocrine communication networks studied in experimental models
Sermorelin (a growth hormone-releasing peptide) stimulates endogenous GH production through the pituitary, while semaglutide (a GLP-1 receptor agonist) slows gastric emptying and reduces appetite signaling